Skip to content
healthcare.dev

atovaquone

NDC 68462-421, atovaquone, suspension, from Glenmark Pharmaceuticals Inc., USA.

Product NDC
68462-421
Status
Listed
Labeler
Glenmark Pharmaceuticals Inc., USA
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209685
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68462-421 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATOVAQUONE750 mg/5mL

Pharmacologic classes

Antimalarial [EPC]; Antiprotozoal [EPC]

Package NDCNDC-11Package
68462-421-2168462042121210 mL in 1 BOTTLE (68462-421-21)
68462-421-696846204216942 POUCH in 1 CARTON (68462-421-69) / 5 mL in 1 POUCH

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9045ba6f-938e-4717-bfa2-a3efe52f04cd
  • NADAC price for package 68462042121

    GET /v1/drugs/nadac/68462042121
  • NADAC price for package 68462042169

    GET /v1/drugs/nadac/68462042169

Use it

Look up 68462-421 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68462-421 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68462-421. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.